The fact that ALS-associated mutations of TARDBP mostly occur in the IDR has led to the idea that pathological phase transitions of TDP-43 mediated by altered homotypic and heterotypic interactions through IDR contribute to ALS pathogenesis. Here, TARDBP is linked to amyotrophic lateral sclerosis.